Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1999 1
2002 2
2005 2
2006 1
2009 1
2010 1
2011 2
2012 3
2013 3
2014 5
2015 4
2016 3
2017 4
2018 1
2019 5
2021 4
2022 2
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

43 results

Results by year

Filters applied: . Clear all
Page 1
Mucosal boosting enhances vaccine protection against SARS-CoV-2 in macaques.
McMahan K, Wegmann F, Aid M, Sciacca M, Liu J, Hachmann NP, Miller J, Jacob-Dolan C, Powers O, Hope D, Wu C, Pereira J, Murdza T, Mazurek CR, Hoyt A, Boon ACM, Davis-Gardner M, Suthar MS, Martinot AJ, Boursiquot M, Cook A, Pessaint L, Lewis MG, Andersen H, Tolboom J, Serroyen J, Solforosi L, Costes LMM, Zahn RC, Barouch DH. McMahan K, et al. Among authors: costes lmm. Nature. 2024 Feb;626(7998):385-391. doi: 10.1038/s41586-023-06951-3. Epub 2023 Dec 14. Nature. 2024. PMID: 38096903 Free PMC article.
Serum Immune Profiling in Paediatric Crohn's Disease Demonstrates Stronger Immune Modulation With First-Line Infliximab Than Conventional Therapy and Pre-Treatment Profiles Predict Clinical Response to Both Treatments.
Jongsma MME, Costes LMM, Tindemans I, Cozijnsen MA, Raatgreep RHC, van Pieterson M, Li Y, Escher JC, de Ridder L, Samsom JN. Jongsma MME, et al. Among authors: costes lmm. J Crohns Colitis. 2023 Aug 21;17(8):1262-1277. doi: 10.1093/ecco-jcc/jjad049. J Crohns Colitis. 2023. PMID: 36934327 Free PMC article. Clinical Trial.
Neural networks in intestinal immunoregulation.
Costes LM, Boeckxstaens GE, de Jonge WJ, Cailotto C. Costes LM, et al. Organogenesis. 2013 Jul-Sep;9(3):216-23. doi: 10.4161/org.25646. Epub 2013 Jul 18. Organogenesis. 2013. PMID: 23867810 Free PMC article. Review.
Booster with Ad26.COV2.S or Omicron-adapted vaccine enhanced immunity and efficacy against SARS-CoV-2 Omicron in macaques.
Solforosi L, Costes LMM, Tolboom JTBM, McMahan K, Anioke T, Hope D, Murdza T, Sciacca M, Bouffard E, Barrett J, Wu C, Hachmann N, Miller J, Yu J, He X, Jacob-Dolan C, Huber SKR, Dekking L, Chamanza R, Choi Y, Boer KF, Barouch DH, Schuitemaker H, Zahn RC, Wegmann F. Solforosi L, et al. Among authors: costes lmm. Nat Commun. 2023 Apr 7;14(1):1944. doi: 10.1038/s41467-023-37715-2. Nat Commun. 2023. PMID: 37029141 Free PMC article.
Microplastics contamination in pearl-farming lagoons of French Polynesia.
Gardon T, El Rakwe M, Paul-Pont I, Le Luyer J, Thomas L, Prado E, Boukerma K, Cassone AL, Quillien V, Soyez C, Costes L, Crusot M, Dreanno C, Le Moullac G, Huvet A. Gardon T, et al. Among authors: costes l. J Hazard Mater. 2021 Oct 5;419:126396. doi: 10.1016/j.jhazmat.2021.126396. Epub 2021 Jun 11. J Hazard Mater. 2021. PMID: 34171671 Free article.
Prevalence of primary immunodeficiencies in France is underestimated.
Mahlaoui N, Jais JP, Brosselin P, Mignot C, Beaurain B, Brito C, Costes L, Courteille V, De Vergnes N, Alcaïs A, Fischer A; CEREDIH Prevalence Study Collaborators. Mahlaoui N, et al. Among authors: costes l. J Allergy Clin Immunol. 2017 Dec;140(6):1731-1733. doi: 10.1016/j.jaci.2017.06.020. Epub 2017 Jul 18. J Allergy Clin Immunol. 2017. PMID: 28732644 No abstract available.
Genetic diagnosis of primary immunodeficiencies: A survey of the French national registry.
Mahlaoui N, Picard C, Bach P, Costes L, Courteille V, Ranohavimparany A, Alcaïs A, Jais JP, Fischer A; CEREDIH French PID study group. Mahlaoui N, et al. Among authors: costes l. J Allergy Clin Immunol. 2019 Apr;143(4):1646-1649.e10. doi: 10.1016/j.jaci.2018.12.994. Epub 2019 Jan 9. J Allergy Clin Immunol. 2019. PMID: 30639347 No abstract available.
Impact of the COVID-19 pandemic and associated lockdown measures on the management, health, and behavior of the cystic fibrosis population in France during 2020 (MUCONFIN).
Oubaya N, Pombet T, Delestrain C, Remus N, Douvry B, Grenet D, Corvol H, Thouvenin G, Prulière-Escabasse V, Mounir H, Argoud D, Fretigne C, Costes L, Mackiewicz MP, Jung C, Ahamada L, Lanone S, Maitre B, Bégot AC, Epaud R. Oubaya N, et al. Among authors: costes l. Front Public Health. 2022 Nov 14;10:978627. doi: 10.3389/fpubh.2022.978627. eCollection 2022. Front Public Health. 2022. PMID: 36452951 Free PMC article.
An appraisal of the frequency and severity of noninfectious manifestations in primary immunodeficiencies: A study of a national retrospective cohort of 1375 patients over 10 years.
Alligon M, Mahlaoui N, Courteille V, Costes L, Afonso V, Randrianomenjanahary P, de Vergnes N, Ranohavimparany A, Vo D, Hafsa I, Bach P, Benoit V, Garcelon N, Fischer A; members of the CEREDIH French PID study group. Alligon M, et al. Among authors: costes l. J Allergy Clin Immunol. 2022 Jun;149(6):2116-2125. doi: 10.1016/j.jaci.2021.12.790. Epub 2022 Jan 12. J Allergy Clin Immunol. 2022. PMID: 35031273
43 results